RS

Serbia

1962 clinical trials

Find Trials

Clinical Trials (1962)

Showing 20 of 1,962 trialsScroll for more

Pompe Disease Registry Protocol

Recruiting
NCT04464226Phase 32 sites

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Active Not Recruiting
NCT05070858Phase 31 site

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Active Not Recruiting
NCT05269004Phase 32 sites

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Active Not Recruiting
NCT06238622Phase 33 sites

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Active Not Recruiting
NCT06282575Phase 33 sites

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Recruiting
NCT06424288Phase 311 sites

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Recruiting
NCT06858579Phase 34 sites

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Recruiting

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Recruiting
NCT06935370Phase 39 sites

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Recruiting
NCT06996782Phase 1/23 sites

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Recruiting
NCT07010159Phase 2/32 sites

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

Recruiting
NCT07064473Phase 38 sites

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Recruiting
NCT07288216Phase 22 sites

Transition to KPL-387 Monotherapy Dosing & Administration Study

Recruiting
NCT07409181Phase 22 sites

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Recruiting
NCT07630714Phase 22 sites

A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

Recruiting

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Recruiting
NCT07691970Phase 32 sites

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Recruiting
NCT04957719Phase 317 sites

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

Enrolling By Invitation
NCT06585787Phase 38 sites

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Recruiting